22-29125306-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001039570.3(KREMEN1):āc.521A>Gā(p.Asn174Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000161 in 1,614,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001039570.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KREMEN1 | NM_001039570.3 | c.521A>G | p.Asn174Ser | missense_variant | 5/9 | ENST00000400335.9 | NP_001034659.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KREMEN1 | ENST00000400335.9 | c.521A>G | p.Asn174Ser | missense_variant | 5/9 | 1 | NM_001039570.3 | ENSP00000383189.4 | ||
KREMEN1 | ENST00000407188.5 | c.515A>G | p.Asn172Ser | missense_variant | 5/9 | 1 | ENSP00000385431.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152138Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249450Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135338
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727246
GnomAD4 genome AF: 0.000105 AC: 16AN: 152138Hom.: 0 Cov.: 31 AF XY: 0.000175 AC XY: 13AN XY: 74322
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2024 | The c.521A>G (p.N174S) alteration is located in exon 5 (coding exon 5) of the KREMEN1 gene. This alteration results from a A to G substitution at nucleotide position 521, causing the asparagine (N) at amino acid position 174 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at